We recently published a list of Top 10 Insider Purchases Last Month. In this article, we are going to take a look at where ...

The deal gives the Swiss pharma access to an experimental amylin-targeting treatment it will test in combination with drugs ...

The Los Angeles Dodgers are exercising the utmost caution with their two-way superstar Shohei Ohtani. Read more at MLB Trade ...

It was a busy week in the IG primary, which exceeded supply expectations and saw two jumbo M&A offerings land and be quickly absorbed by investors. The ECM arena also saw active sessions, with IPOs, ...

Metsera’s (NASDAQ:MTSR – Get Free Report) quiet period is set to expire on Wednesday, March 12th. Metsera had issued 15,277,778 shares in its initial public offering on January 31st. The total size of ...

We recently published a list of 10 Stocks With At Least $20 Million In Insider Spending Recently. In this article, we are ...

The newly listed clinical-stage biotechnology company, Metsera Inc. rose 15.01% on Monday as the broader markets declined.

We recently published a list of 10 Stocks With At Least $10 Million In Insider Spending Recently. In this article, we are ...

A licensing deal with Denmark’s Gubra gives the immunology giant control of an experimental therapy that could compete with ...

Specialty; Amneal Pharmaceuticals Inc. Jason Daly; Senior Vice President, Chief Legal Officer, Corporate Secretary; Amne ...

Amneal Pharmaceuticals Inc (AMRX) reports robust financial performance with double-digit growth across key segments and strategic moves into new markets.